United States

Analyst Research

Report Title Price
Provider : GlobalData
Provider : Pechala's Reports
Provider : Wright Reports
Provider : New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ampio Pharmaceuticals Inc announces positive results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion

Monday, 18 Aug 2014 08:00am EDT 

Ampio Pharmaceuticals Inc:Says 6 weeks results of the open label portion of the multiple injections of Ampion into the knees of patients (n=7) with osteoarthritis (OA).Results so far are encouraging. 

Related Company News

Company Quote

-0.05 -1.28%
25 May 2016